FDA 483 - Aphena Pharma Solutions-Maryland LLC - February 20, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Aphena Pharma Solutions - Maryland, LLC in Easton, MD, revealed significant deficiencies in quality control and investigation processes. The firm failed to thoroughly investigate unexplained discrepancies and out-of-specification results, and its Quality Assurance unit did not adequately verify batch record accuracy. Additionally, the company lacked procedures to evaluate raw material and component suppliers, contributing to persistent hair contamination in drug products.
ID · f9cf7982-d7c3-4ceb-94e8-81f2da6bd523